GDC-0941 Bimesylate
- CAS No.
- 957054-33-0
- Chemical Name:
- GDC-0941 Bimesylate
- Synonyms
- GDC-0941 Bimesylate;Pictilisib mesylate;GDC-0941 dimesylate;Pictilisib (GDC-0941);GDC-0941 (2 MeSO3H salt);GDC 0941 (2 MeSO3H salt);Pictilisib dimethanesulfonate;GDC-0941 (diMethanesulfonate);GDC-0941 Bimesylate USP/EP/BP;GDC-0941 BiMesylate/pictilisib
- CBNumber:
- CB82509226
- Molecular Formula:
- C24H30N7O6S3
- Molecular Weight:
- 608.7333
- MDL Number:
- MOL File:
- 957054-33-0.mol
| Melting point | >280°C (dec.) |
|---|---|
| storage temp. | Refrigerator |
| solubility | DMSO (Slightly, Heated), Methanol (Sparingly) |
| form | Solid |
| color | White to Pale Yellow |
| FDA UNII | G3D7HF2GS9 |
GDC-0941 Bimesylate price More Price(20)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Usbiological | 012740 | GDC-0941 Bimesylate | 957054-33-0 | 10mg | $460 | 2021-12-16 | Buy |
| TRC | G300000 | GDC-0941Bimesylate | 957054-33-0 | 50mg | $790 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | KIN0000849 | GDC-0941 BISMESYLATE 95.00% | 957054-33-0 | 100MG | $1963.5 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | KIN0000849 | GDC-0941 BISMESYLATE 95.00% | 957054-33-0 | 5MG | $416 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | KIN0000849 | GDC-0941 BISMESYLATE 95.00% | 957054-33-0 | 10MG | $750.75 | 2021-12-16 | Buy |
GDC-0941 Bimesylate Chemical Properties,Uses,Production
Description
Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2.
In vitro
GDC-0941 is equipotent against PI3Kα and PI3Kδ as well as PI3Kα mutants E545-K and H1047-R, displaying modest levels of selectivity against PI3Kβ (10-fold) and PI3Kγ (25-fold), and greater levels of selectivity against members of PI3K class II, III, and IV, including C2β, Vps34, DNA-PK, and mTOR. GDC-0941 potently inhibits the phosphorylation of Akt in U87MG, PC3, and MDA-MB-361 cells with IC50 of 46 nM, 37 nM, and 28 nM, respectively. GDC-0941 inhibits the proliferation of U87MG, A2780, PC3, and MDA-MB-361 cells with IC50 of 0.95 μM, 0.14 μM, 0.28 μM, and 0.72 μM, respectively. GDC-0941 treatment potently inhibits the proliferation of both trastuzumab-sensitive and-insensitive HER2-amplified cells with IC50 of 149-944 nM. GDC-0941 inhibits proliferation of HER2-amplified cells that harbor PIK3CA mutations with IC50 of <500 nM, and effectively inhibits both proliferation and viability of HER2-amplified breast cancer cells that are resistant to trastuzumab due to PTEN loss. GDC-0941 significantly inhibits the growth of HCT116, DLD1 and HT29 cells with GI50 of 1081 nM, 1070 nM and 157 nM, respectively. GDC-0941 inhibits tumor cell proliferation, induces apoptosis and suppresses centroblast population.
In vivo
Administration of GDC-0941 at 75 mg/kg/day displays significant inhibitory effect against established human U87MG glioblastoma xenografts in female NCr athymic mice, with tumor growth inhibition of 83%. Oral administration of GDC-0941 at 150 mg/kg/day inhibits the growth of HER2-amplified, trastuzumab-resistant MDA-MB-361.1 xenografts in mice, and significantly delays the tumor progression, in association with potent induced apoptosis in tumors. GDC-0941 (75 mg/kg/day) treatment for 2 weeks induces ~40% reduction in tumor volume of spontaneous B-cell follicular lymphomas developed in PTEN+/-LKB1+/hypo mice, accompanied by ablation of phosphorylation of Akt, S6K and SGK (serum and glucocorticoid protein kinase) protein kinases.
Chemical Properties
Off-White Solid
Uses
Potent inhibitor of Phosphatidylinositol 3-kinase (PI3K)
Biological Activity
gdc-0941 is a novel selective class i phosphatidylinositol-3-kinase (pi3k) inhibitor. activation of pi3k/akt signaling pathway is frequently associated with tumorigenesis. deregulation of this pathway occurs frequently with a variety of cancers and may contribute to the resistance to many anticancer agents. [1] developing novel small molecules that specifically block the pi3k/akt pathway may inhibit tumor growth. gdc-0941 is designed to bind the atp-binding pocket of pi3k and to prevent formation of phosphatidylinositol-3, 4, 5-triphosphate (pip3), a second messenger that transmits pi3k downstream signals. [2, 3] it binds to pi3k in an atp-competitive manner.gdc-0941 is a potent small-molecule thieno [3, 2-d] pyrimidine inhibitor of the class i pi3k. it is highly selective against isoforms p110( and p110( with ic50 of 3 nm, and moderately selective against isoforms p110( and p110( with ic50s of 33 nm and 75 nm, respectively.gdc-0941 inhibits cell proliferation in vitro and in vivo. it causes growth inhibition in a variety of cancer cell lines, including a2780, mda-mb-361, pc3, and u87mg. [2] it also inhibits the growth of trastuzumab–sensitive and –resistant her2-amplied cancer cells which harbor p110( mutations or pten loss. [4] gdc-0941 also reduces tumor volume in different xenograft models. [4]gdc-0941 can be taken orally.
target
PI3Kα
References
[1]yuan tl, cantley lc. pi3k pathway alterations in cancer: variations on a theme. oncogene. 2008;27:5497-5510.
[2]folkes aj, ahmadi k, alderton wk, et al. the identification of 2-(1h-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (gdc-0941) as a potent, selective, orally bioavailable inhibitor of class i pi3 kinase for the treatment of cancer. j med chem. 2008; 51: 5522-5532.
[3]knight za, shokat km. chemically targeting the pi3k family. biochem soc trans. 2007; 35: 245-249.
[4]junttila tt, akita rw, parsons k, fields c, lewis phillips gd, friedman ls, sampath d, sliwkowski mx. ligand-independent her2/her3/pi3k complex is disrupted by trastuzumab and is effectively inhibited by the pi3k inhibitor gdc-0941. br j cancer. 2011; 104(7): 1116-25.
GDC-0941 Bimesylate Preparation Products And Raw materials
Raw materials
Preparation Products
GDC-0941 Bimesylate Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hubei xin bonus chemical co. LTD | 86-13657291602 | linda@hubeijusheng.com | CHINA | 22968 | 58 |
| career henan chemical co | +86-0371-86658258 15093356674; | factory@coreychem.com | China | 29826 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
| Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 | 1026@dideu.com | China | 29474 | 58 |
| Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10523 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6393 | 58 |
| Hefei TNJ Chemical Industry Co.,Ltd. | 0551-65418684 +8618949823763 | sales@tnjchem.com | China | 25363 | 58 |
| LEAPCHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 43348 | 58 |
| Shanghai Acmec Biochemical Technology Co., Ltd. | +undefined18621343501 | product@acmec-e.com | China | 33349 | 58 |
| Aladdin Scientific | +1-833-552-7181 | sales@aladdinsci.com | United States | 57511 | 58 |
View Lastest Price from GDC-0941 Bimesylate manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2020-01-03 | Pictilisib dimethanesulfonate
957054-33-0
|
US $9.80 / KG | 1KG | ≥98% | 20 tons | Career Henan Chemical Co | |
 |
2020-01-01 | Pictilisib dimethanesulfonate
957054-33-0
|
US $9.80 / KG | 1KG | ≥98% | 20 tons | Career Henan Chemical Co |
-
- Pictilisib dimethanesulfonate
957054-33-0
- US $9.80 / KG
- ≥98%
- Career Henan Chemical Co
-
- Pictilisib dimethanesulfonate
957054-33-0
- US $9.80 / KG
- ≥98%
- Career Henan Chemical Co